the staff of the Ridgewood blog
Hackensack NJ, the Food and Drug Administration (FDA) approved two gene editing therapies for the treatment of sickle cell disease. Experts hope it’s a cure, the first, for the inherited blood disorder that affects more than 100,000 Americans with extreme pain.
